<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-pharmaceuticals-13-00096">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mathias</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>German</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Murray</surname>
    <given-names>B.P.</given-names>
   </name>
   <name>
    <surname>Wei</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Jain</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>West</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Warren</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Kearney</surname>
    <given-names>B.P.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacokinetics and pharmacodynamics of GS-9350: A novel pharmacokinetic enhancer without anti-HIV activity</article-title>
  <source>Clin. Pharmacol. Ther.</source>
  <year>2010</year>
  <volume>87</volume>
  <fpage>322</fpage>
  <lpage>329</lpage>
  <pub-id pub-id-type="doi">10.1038/clpt.2009.228</pub-id>
  <pub-id pub-id-type="pmid">20043009</pub-id>
 </element-citation>
</ref>
